SNS-595、及びその使用方法 - MILLENNIUM PHARMACEUTICALS, INC.

Title:

SNS-595、及びその使用方法

Document Type and Number:

Japanese Patent JP2007529524

Kind Code:

A

Abstract:

The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound to the patient in a dose of 10 mg/m 2 to 100 mg/m 2 .

More Like This:

JP2016193893	VIABLE CELL PREPARATION
JP2017043634	FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER
JP2017527303	Therapeutic use of P75NTR neurotrophin-binding protein

Inventors:

Michelle alkyne
Jennifer Hide
Ducan Walker
Jasmine Uligft

Application Number:

JP2007503972A

Publication Date:

October 25, 2007

Filing Date:

March 14, 2005

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MILLENNIUM PHARMACEUTICALS, INC.

International Classes:

A61K45/00; A61K31/282; A61K31/337; A61K31/35; A61K31/395; A61K31/407; A61K31/4375; A61K31/44; A61K31/4745; A61K31/513; A61K31/519; A61K31/52; A61K31/704; A61K31/7048; A61K31/7068; A61K33/24; A61K38/00; A61K51/00; A61P13/08; A61P35/00; A61P35/02; A61P43/00; F24S10/70

Domestic Patent References:

JPH09221424A	1997-08-26
JP2002519010A	2002-07-02

Foreign References:

WO2002020500A2	2002-03-14
WO1995034559A1	1995-12-21
WO2002036171A1	2002-05-10

Attorney, Agent or Firm:

Toru Ishikawa

Previous Patent: 肥満症を治療するためのオピオイド受容体拮抗物質としての４−（５−ア�...

Next Patent: 鼻腔内ベンゾジアゼピン組成物